Treatment with azathioprine and cyclic methylprednisolone has little or no effect on bioactivity in anti-interferon beta antibody-positive patients with multiple sclerosis
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Treatment with azathioprine and cyclic methylprednisolone has little or no effect on bioactivity in anti-interferon beta antibody-positive patients with multiple sclerosis. / Ravnborg, Mads; Bendtzen, K; Christensen, O; Jensen, P E H; Hesse, D; Tovey, M G; Sørensen, P S.
I: Multiple Sclerosis, Bind 15, Nr. 3, 01.03.2009, s. 323-8.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Treatment with azathioprine and cyclic methylprednisolone has little or no effect on bioactivity in anti-interferon beta antibody-positive patients with multiple sclerosis
AU - Ravnborg, Mads
AU - Bendtzen, K
AU - Christensen, O
AU - Jensen, P E H
AU - Hesse, D
AU - Tovey, M G
AU - Sørensen, P S
PY - 2009/3/1
Y1 - 2009/3/1
N2 - It is unknown whether immunosuppression of patients who have developed interferon-beta (IFN-beta) neutralizing antibodies (NAbs) hastens disappearance of NAbs in the blood.
AB - It is unknown whether immunosuppression of patients who have developed interferon-beta (IFN-beta) neutralizing antibodies (NAbs) hastens disappearance of NAbs in the blood.
U2 - 10.1177/1352458508099476
DO - 10.1177/1352458508099476
M3 - Journal article
C2 - 19028832
VL - 15
SP - 323
EP - 328
JO - Multiple Sclerosis Journal
JF - Multiple Sclerosis Journal
SN - 1352-4585
IS - 3
ER -
ID: 19662914